您的位置: 首页 > 农业专利 > 详情页

NOUVEL ARNMI PRÉCURSEUR ET APPLICATION DE CE DERNIER DANS LE TRAITEMENT DE TUMEURS
专利权人:
Ltd.;Jiangsu Micromedmark Biotech Co.
发明人:
ZHANG, Chenyu,ZENG, Ke,CHEN, Xi,ZHANG, Junfeng,LIANG, Hongwei
申请号:
EP15861258
公开号:
EP3222721A4
申请日:
2015.11.17
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
Provided are a precursor miRNA and application thereof in a tumor treatment. The precursor miRNA from the 5' end to 3' end has a structure presented as formula I: B1 is anti-miRNA-214-5p; B2 is an essentially complementary sequence or a totally complementary sequence to B1, and B2 and C are not complementary; C is a sequence having a stem-loop structure; A1 and A2 are respectively RNA sequences having no or 4-5 bases freely selected bases respectively; the precursor miRNA shown can be processed to form anti-miRNA-214 in a host, and only anti-miRNA-214-5p but not anti-miRNA-214-3p is expressed in the anti-miRNA-214.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充